Great attention for SpectraCure in Boston
SpectraCure received a lot of attention around its clinical study results at the World Conference in Boston, attended by world leading clinical researchers.On Wednesday, July 3rd, SpectraCure presented results from the company's phase 1 study at the 17th International Photodynamic Association World Congress in Boston, USA. Johannes Swartling, CTO of SpectraCure held the presentation after an invitation from the conference organizers. The lecture was well attended and received with great interest.The conference was attended by a total of 450 participants. Host of the event was Professor